Chuanpeng Dong

1.4k citations
35 papers · 640 indexed · h-index 17
Topics
RNA modifications and cancer (10 papers)Ferroptosis and cancer prognosis (8 papers)Cancer-related molecular mechanisms research (8 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Chuanpeng Dong

33 papers receiving 635 citations

Peers

Chuanpeng Dong
Comparison fields: 5 of 76
  • Molecular Biology 378
  • Cancer Research 199
  • Oncology 130
  • Pulmonary and Respiratory Medicine 126
  • Neurology 73
Replace Alex Campos with:
Alex Campos United States
Helena Joyce Ireland
Esra Göv Türkiye
Krithika Bhuvaneshwar United States
Xiaozeng Lin Canada
Renee Rubio United States
Pau Badia-i-Mompel Germany
David N. Rider United States
Young‐Kyoung Lee South Korea
Chuanpeng Dong relative to Alex Campos United States Alex Campos's profile →
Citations per field
00.5×1.5×2.3×
Alex Campos · 1×
Citations per year

Countries citing papers authored by Chuanpeng Dong

Since Specialization
Citations

This map shows the geographic impact of Chuanpeng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanpeng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanpeng Dong more than expected).

Fields of papers citing papers by Chuanpeng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanpeng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanpeng Dong. The network helps show where Chuanpeng Dong may publish in the future.

Co-authorship network of co-authors of Chuanpeng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanpeng Dong. A scholar is included among the top collaborators of Chuanpeng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanpeng Dong. Chuanpeng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 6
6 7
7 24
8 25
9 27
10 5
11 70
12 5
13 22
14 21
15 10
16 46
17 13
18 19
19 40
20 25

About Chuanpeng Dong

Chuanpeng Dong is a scholar working on Cancer Research, Neurology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 640 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (199 citations), Neurology (73 citations) and Molecular Biology (378 citations). Chuanpeng Dong has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Yunlong Liu, Lei Liu, Andy P. Tsai, Miguel Moutinho, Gang Liu, Kwangsik Nho, Bruce T. Lamb, Gary E. Landreth, Adrian L. Oblak and Peter Bor‐Chian Lin. Their work appears in journals such as Blood, Nature Biotechnology and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026